James Cancer Hospital

Columbus, Ohio 43210

1 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), Advanced Cancer, Anemia, Sickle Cell, Diffuse Large B-cell Lymphoma, Metastatic Urothelial Carcinoma, Refractory Anemia With Excess of Blasts (RAEB), Renal Cell Carcinoma, Scleroderma, Diffuse

Studies at this site

• Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
• A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer — Completed
• Study of the Combination of ACP-196 and Pembrolizumab in Subjects With Platinum Resistant Urothelial Bladder Cancer — Completed
• Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients — Completed
• Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions — Completed
• Accuracy Testing of the Chromosomal Aberration and Gene Mutation Markers of the AMLProfiler — Stopped early
• A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Stopped early